These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. SapC-DOPS - a Phosphatidylserine-targeted Nanovesicle for selective Cancer therapy. N'Guessan KF; Patel PH; Qi X Cell Commun Signal; 2020 Jan; 18(1):6. PubMed ID: 31918715 [TBL] [Abstract][Full Text] [Related]
9. SapC-DOPS nanovesicles as targeted therapy for lung cancer. Zhao S; Chu Z; Blanco VM; Nie Y; Hou Y; Qi X Mol Cancer Ther; 2015 Feb; 14(2):491-8. PubMed ID: 25670331 [TBL] [Abstract][Full Text] [Related]
10. Systemic enzyme delivery by blood-brain barrier-penetrating SapC-DOPS nanovesicles for treatment of neuronopathic Gaucher disease. Sun Y; Liou B; Chu Z; Fannin V; Blackwood R; Peng Y; Grabowski GA; Davis HW; Qi X EBioMedicine; 2020 May; 55():102735. PubMed ID: 32279952 [TBL] [Abstract][Full Text] [Related]
11. Biotherapy of Brain Tumors with Phosphatidylserine-Targeted Radioiodinated SapC-DOPS Nanovesicles. Davis HW; Vallabhapurapu SD; Chu Z; Wyder MA; Greis KD; Fannin V; Sun Y; Desai PB; Pak KY; Gray BD; Qi X Cells; 2020 Aug; 9(9):. PubMed ID: 32854321 [TBL] [Abstract][Full Text] [Related]
12. In vivo optical imaging of brain tumors and arthritis using fluorescent SapC-DOPS nanovesicles. Chu Z; LaSance K; Blanco V; Kwon CH; Kaur B; Frederick M; Thornton S; Lemen L; Qi X J Vis Exp; 2014 May; (87):. PubMed ID: 24837630 [TBL] [Abstract][Full Text] [Related]
13. Optical and nuclear imaging of glioblastoma with phosphatidylserine-targeted nanovesicles. Blanco VM; Chu Z; LaSance K; Gray BD; Pak KY; Rider T; Greis KD; Qi X Oncotarget; 2016 May; 7(22):32866-75. PubMed ID: 27096954 [TBL] [Abstract][Full Text] [Related]
14. Imaging of brain tumors with paramagnetic vesicles targeted to phosphatidylserine. Winter PM; Pearce J; Chu Z; McPherson CM; Takigiku R; Lee JH; Qi X J Magn Reson Imaging; 2015 Apr; 41(4):1079-87. PubMed ID: 24797437 [TBL] [Abstract][Full Text] [Related]
15. Cancer-selective targeting and cytotoxicity by liposomal-coupled lysosomal saposin C protein. Qi X; Chu Z; Mahller YY; Stringer KF; Witte DP; Cripe TP Clin Cancer Res; 2009 Sep; 15(18):5840-51. PubMed ID: 19737950 [TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 4 can recognize SapC-DOPS to stimulate macrophages to express several cytokines. Lu K; Zhao G; Lu H; Zhao S; Song Y; Qi X; Hou Y Inflamm Res; 2011 Feb; 60(2):153-61. PubMed ID: 20853174 [TBL] [Abstract][Full Text] [Related]
17. Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer. N'Guessan KF; Davis HW; Chu Z; Vallabhapurapu SD; Lewis CS; Franco RS; Olowokure O; Ahmad SA; Yeh JJ; Bogdanov VY; Qi X Mol Ther; 2020 Aug; 28(8):1876-1886. PubMed ID: 32516572 [TBL] [Abstract][Full Text] [Related]
18. Phosphatidylserine: A cancer cell targeting biomarker. Sharma B; Kanwar SS Semin Cancer Biol; 2018 Oct; 52(Pt 1):17-25. PubMed ID: 28870843 [TBL] [Abstract][Full Text] [Related]